These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 557938)

  • 1. A quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory.
    Kim M; Woo KB; Perry S
    Ann Biomed Eng; 1977 Mar; 5(1):12-33. PubMed ID: 557938
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of cell kinetics in the development of drug combinations.
    Valeriote FA
    Pharmacol Ther; 1979; 4(1):1-33. PubMed ID: 461499
    [No Abstract]   [Full Text] [Related]  

  • 3. Duration of the dormant state in an established cell line of human hematopoietic cells.
    Clarkson BD; Fried J; Chou TC; Strife A; Ferguson R; Sullivan S; Kitahara T; Oyama A
    Cancer Res; 1977 Dec; 37(12):4506-22. PubMed ID: 336195
    [No Abstract]   [Full Text] [Related]  

  • 4. The chemotherapy of human and animal acute leukemia.
    Goldin A; Sandberg JS; Henderson ES; Newman JW; Frei E; Holland JF
    Cancer Chemother Rep; 1971 Nov; 55(4):309-505. PubMed ID: 4945857
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems in the treatment of slow-growing tumors.
    Van Putten LM
    Recent Results Cancer Res; 1975; (52):225-33. PubMed ID: 1235002
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of cell kinetics in cancer chemotherapy.
    Valeriote FA; Edelstein MB
    Semin Oncol; 1977 Jun; 4(2):217-26. PubMed ID: 327554
    [No Abstract]   [Full Text] [Related]  

  • 7. R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878).
    Atassi G; Schaus C; Tagnon HJ
    Eur J Cancer (1965); 1975 Sep; 11(9):609-14. PubMed ID: 1220976
    [No Abstract]   [Full Text] [Related]  

  • 8. Resting cells in L1210 and JB-1 ascites tumors with special emphasis on recycling.
    Hartmann NR; Dombernowsky P; Bichel P
    Cancer Treat Rep; 1976 Dec; 60(12):1861-70. PubMed ID: 1026340
    [No Abstract]   [Full Text] [Related]  

  • 9. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
    Schwartz SA; Morgenstern B; Capizzi RL
    Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing concepts of treatment in acute leukemia.
    Clarkson BD; Fried J
    Med Clin North Am; 1971 May; 55(3):561-600. PubMed ID: 4930457
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of chemotherapy on cell kinetics. II. Rauscher and Moloney murine leukemias].
    Najean Y; Faille A
    Nouv Rev Fr Hematol; 1973; 13(1):51-69. PubMed ID: 4352960
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor effects of azaserine and DON.
    Burchenal JH
    Cancer Treat Rep; 1979 Jun; 63(6):1031-2. PubMed ID: 466642
    [No Abstract]   [Full Text] [Related]  

  • 13. Are cell kinetic data relevant for the design of tumour chemotherapy schedules?
    van Putten LM
    Cell Tissue Kinet; 1974 Sep; 7(5):493-504. PubMed ID: 4607700
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced antitumor effect of cytosine arabinoside given in a schedule dictated by kinetic studies in vivo.
    Young RC; Goldberg D; Schein PS
    Biochem Pharmacol; 1973 Jan; 22(2):277-80. PubMed ID: 4763256
    [No Abstract]   [Full Text] [Related]  

  • 15. Teaching cancer chemotherapy by means of a computer simulation.
    Jean Y; De Traversay J; Lemieux P
    Int J Biomed Comput; 1994 Aug; 36(4):273-80. PubMed ID: 8002104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response.
    Burke PJ; Karp JE; Vaughan WP
    J Natl Cancer Inst; 1981 Sep; 67(3):529-38. PubMed ID: 6944525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of optimal drug administration strategies for cancer-chemotherapy in the framework of systems theory.
    Acharya RS; Sundareshan MK
    Int J Biomed Comput; 1984; 15(2):139-50. PubMed ID: 6724730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a chronotherapy of neoplasia: tolerance of treatment depends upon host rhythms.
    Halberg F; Haus E; Cardoso SS; Scheving LE; Kühl JF; Shiotsuka R; Rosene G; Pauly JE; Runge W; Spalding JF; Lee JK; Good RA
    Experientia; 1973 Aug; 29(8):909-34. PubMed ID: 4582086
    [No Abstract]   [Full Text] [Related]  

  • 19. The cell cycle and its significance for cancer treatment.
    Hill BT; Baserga R
    Cancer Treat Rev; 1975 Sep; 2(3):159-75. PubMed ID: 1104161
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of the transplantable acute leukemia L5222 in rats.
    Zeller WJ; Ivankovic S; Schmähl D
    Cancer Res; 1975 May; 35(5):1168-74. PubMed ID: 1120307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.